HMBD-001 in Advanced HER3 Positive Solid Tumours
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Bladder Cancer|Triple Negative Breast Cancer|Castration-resistant Prostate Cancer|Cervical Cancer|RAS Wild Type Colorectal Cancer|Endometrial Cancer|Gastric Cancer|Hepatocellular Carcinoma (HCC)|Melanoma|Non-small Cell Lung Cancer (NSCLC)|Oesophageal Cancer|Ovarian Cancer|Pancreatic Cancer|Squamous Cell Cancer of the Head and Neck
Interventions: DRUG: HMBD-001
Sponsor: Cancer Research UK
Collaborators: Hummingbird Bioscience